Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

6.5%

3 terminated out of 46 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

15%

7 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed with results

Key Signals

4 with results83% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (26)
Early P 1 (1)
P 1 (1)
P 2 (3)
P 3 (4)
P 4 (3)

Trial Status

Completed15
Recruiting13
Not Yet Recruiting6
Unknown3
Terminated3
Active Not Recruiting3

Trial Success Rate

83.3%

Benchmark: 86.6%

Based on 15 completed trials

Clinical Trials (46)

Showing 20 of 20 trials
NCT07743814Phase 3Not Yet Recruiting

EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) OF PRIMARY MOTOR CORTEX ON HEADACHE FREQUENCY IN PATIENTS WITH CHRONIC MIGRAINE

NCT07652034Not Yet Recruiting

EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine

NCT07500558Not ApplicableRecruitingPrimary

Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for Pain Alleviation in Chronic Refractory Migraine.

NCT07617441RecruitingPrimary

The Neuroanatomical and Psychological Correlates of Suggestibility in Patients With Non-Responsive Chronic Migraine

NCT07071506Not ApplicableRecruiting

New Methods for Evaluating Preventive Migraine Treatment

NCT07223008Not ApplicableRecruiting

Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine

NCT07535723Not ApplicableNot Yet RecruitingPrimary

Botulinum Toxin and/or Greater Occipital Nerve Block for Patients With Chronic Migraine

NCT07497646Not ApplicableCompletedPrimary

Repeated Bilateral Greater Occipital Nerve Blockade in Chronic Migraine and Chronic Tension-Type Headache

NCT06891118Not ApplicableCompleted

Stellate Ganglion Blockade for Refractory Chronic Migraine

NCT07395908Not ApplicableActive Not RecruitingPrimary

The Effect of Interventional Procedures on Serum CGRP and PACAP-38 Levels in Chronic Migraine

NCT07347067Not ApplicableRecruiting

Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Migraine

NCT07214454Not ApplicableNot Yet RecruitingPrimary

TCDS for the Treatment of Chronic Migraine

NCT07159750Recruiting

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

NCT07087678Not ApplicableNot Yet RecruitingPrimary

Occipital Nerve Stimulation in Chronic Migraine

NCT07040813Phase 3Recruiting

The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy

NCT03526874Phase 3CompletedPrimary

Occipital Blocks for Acute Migraine

NCT06848166Early Phase 1RecruitingPrimary

Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients With Chronic Resistant Migraine

NCT05679908Phase 2Completed

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine

NCT04989413Phase 2TerminatedPrimary

Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine -

NCT06138171Completed

Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia

Scroll to load more

Research Network

Activity Timeline